Status:
UNKNOWN
To Compare Therapeutic Effect of Intravitreal Bevacizumab and Triamcinolone in Resistant Uveitic Cystoid Macular Edema
Lead Sponsor:
Shahid Beheshti University of Medical Sciences
Conditions:
Resistant Cystoid Macular Edema
Eligibility:
All Genders
Phase:
PHASE1
Brief Summary
Cystoid macular edema (CME) is one of the common causes of vision loss in patients with UveitiS .Triamcinolone has been effectively used in reducing CME and improving the vision. Also there are some d...
Detailed Description
This study compare intravitreous injection of triamcinolone and avastin in patients with resistant uveitic cystoid macular edema.
Eligibility Criteria
Inclusion
- Uveitic CME
- Uveitic CME refractory to routine treatment
- Vision better than 5/200 and worse than 20/50
Exclusion
- Mono- Ocular patients
- History of vitrectomy
- Glaucoma or ocular hypertension
- History of other retinal disease that can cause macular edema
- Pregnancy
- Significant media opacity
- Vision better than 20/50
Key Trial Info
Start Date :
August 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2008
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00371111
Start Date
August 1 2006
End Date
September 1 2008
Last Update
July 30 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Masoud Soheilian , MD
Tehran, Tehran Province, Iran, 16666